Who Paid My Doc Search
Menu
Organisation paid for research Program year 2022 Source: CMS Open Payments

Duke Univ Medcl Ctr

Neither a doctor nor a teaching hospital

Research payments

$496,820

131 payments

Through program year 2022, Duke Univ Medcl Ctr is reported as receiving $496,820 in research payments, across 131 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $351,144 12
2021 Research $41,457 6
2020 Research $61,310 50
2019 Research $42,909 63

Breakdown

Who paid Research payments · program years 2019–2022
  1. Janssen Research & Development, LLC $444,061 27 payments
  2. Boehringer Ingelheim Pharmaceuticals, Inc. $42,828 10 payments
  3. Boehringer Ingelheim Pharma GmbH & Co.KG $5,682 62 payments
  4. Boehringer Ingelheim Limited $1,614 10 payments
  5. Boehringer Ingelheim International GmbH $1,356 20 payments
  6. Boehringer Ingelheim RCV GmbH & Co KG $1,279 2 payments
Studies the money was for Research payments · program years 2019–2022
  1. Phase 3 Multi Center Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy Safety Pharmacokinetics and Pharmacodynamics of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis $371,960 10 payments
  2. A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) $52,711 10 payments
  3. DCRI Registry Study $37,602 5 payments
  4. An Open label Extension Study of MOMM281004 to Evaluate the Safety Tolerability and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis $14,417 3 payments
  5. Phase II III anti IL36R induction in UC $5,083 1 payment
  6. A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension PAH $4,972 4 payments
  7. Nintedanib in PF-ILD (extension) $2,970 30 payments
  8. Extension $2,685 36 payments
  9. Phase II/III in UC patients $1,244 1 payment
  10. Dose finding Trial in PPP (Phase II) $1,186 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record